Computer-Assisted Prediction of Toxicity

  • Kurt Enslein
Part of the Life Science Monographs book series (LSMO)


By using statistical structure-activity relationship (SAR) models of toxicological endpoints, it is possible to estimate the expected toxicity from structural and physical characteristics of untested chemicals. Thus, these models can be used for setting testing and developmental priorities, obtaining additional information on given compounds, and, to a lesser degree, determining what substructural factors are most involved in a particular toxicological effect.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Belsley, D. A., Kuh, E., and R. E., Welsch. 1980. Regression Diagnostics. Wiley, New York.CrossRefGoogle Scholar
  2. Chou, J. T., and P. C. Jurs. 1979. Computer-assisted structure-activity studies of chemical carcinogens. N-Nitroso compounds. J. Med. Chem. 22:792–797.CrossRefGoogle Scholar
  3. Costanza, M. C., and A. A. Afifi. 1979. Comparison of stopping rules in forward stepwise discriminant analysis. J. Am. Stat. Assoc. 74:777–785.CrossRefGoogle Scholar
  4. Craig, P. N. 1973. Comparison of Hansch and Free-Wilson approaches to structure-activity correlations. Adv. Chem. 114:115–129.CrossRefGoogle Scholar
  5. Eakin, D. L., E. Hyde, and G. Parker. 1974. The CROSSBOW System. Pestic. Sci. 5:319–326.CrossRefGoogle Scholar
  6. Enslein, K. 1980. Statistical estimates of toxicological and other biological endpoints using structure-activity relationships. Poster Paper at 1st SETAC Conference, Washington ,D.C., 25 November 1980.Google Scholar
  7. Enslein, K., and P. N. Craig. 1978. A toxicity estimation model. J. Environ. Pathol. Toxicol. 2:115–132.Google Scholar
  8. Enslein, K., and P. N. Craig. 1982. Carcinogenesis: A predictive structure activity model. J. Toxicol. Environ. Health 10:521–530.CrossRefGoogle Scholar
  9. Enslein, K., H. S. Wilf, and A. Ralston, eds. 1977. Chapters 4 and 5 in Statistical Methods for Digital Computers. Wiley, New York.Google Scholar
  10. Enslein, K., T. R. Lander, and J. R. Strange. 1983a. Teratogenesis: A statistical structure-activity model. Teratogen. Carcinogen. Mutagen. 3:289–309.CrossRefGoogle Scholar
  11. Enslein, K., T. R. Lander, M. E. Tomb, and W. G. Landis. 1983b. Mutagenicity (Ames): A structure-activity model. Teratogen. Carcinogen. Mutagen. 3:503–513.CrossRefGoogle Scholar
  12. Free, S. M., and J. W. Wilson. 1964. A mathematical contribution to structure and activity studies. J. Med. Chem. 1:295–399.Google Scholar
  13. Hansch, C. 1969. Biological correlations-ansch method. Acc. Chem. Res. 2:232–239.CrossRefGoogle Scholar
  14. Hocking, R. R. 1976. The analysis and selection of variables in linear regression. Biometrics 32:1–49.CrossRefGoogle Scholar
  15. Hodes, L., G. F. Hazard ,R. I. Geran ,and S. Richmann. 1977. A statistical-heuristic method for automated selection of drugs for screening. J. Med. Chem. 20:469–475.CrossRefGoogle Scholar
  16. International Agency for Research on Cancer. 1972–1978. Monographs on the Evaluation of the Car cinogenic Risk of Chemicals to Humans ,Volumes 1–17. International Agency for Research on Cancer ,Lyon.Google Scholar
  17. Jurs ,P. C., J. T. Chous, and M. Yuan. 1979. Computer-assisted studies of chemical carcinogens-A heterogenous data set. J. Med. Chem. 22:476–483.CrossRefGoogle Scholar
  18. Kaufman, J. J. 1979. Quantum chemical and physiochemical influences on structure-activity and drug design. Int. J. Quantum Chem. 16:221–241.CrossRefGoogle Scholar
  19. Lewis, R. J., Sr., ed. 1978. Registry of Toxic Effects of Chemical Substances. National Institute for Occupational Safety and Health, Cincinnati, Ohio.Google Scholar
  20. Loew, G., B. S. Sudhinda, and J. E. J., Ferrel. 1979. Quantum chemical studies of polycyclic aromatic hydrocarbons and their metabolites: Correlations to their carcinogenicity. Chem. Biol. Interact. 26:75–89.CrossRefGoogle Scholar
  21. Marquardt, D. W., and R. D. Snee. 1975. Ridge regression in practice. Am. Statistician 29:3–20.Google Scholar
  22. Purcell, W. P., G. E. Bass, and J. M. Clayton. 1973. Strategy of Drug Design-A Guide to Biological Activity. Wiley, New York.Google Scholar
  23. Schardein, J. L. 1976. Drugs as Teratogens. CRC Press, Cleveland, Ohio.Google Scholar
  24. Shepard, I. H. 1980. Catalog of Teratogenic Agents ,3rd ed. Johns Hopkins University Press, Baltimore ,Maryland.Google Scholar
  25. Siegel, S. 1956. Pp. 127–136 in Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York.Google Scholar
  26. Smith, I. A., G. D. Berger, P. G. Seybold, and M. P. Serve. 1978. Relationships between carcinogenicity and theoretical reactivity indices in polycyclic aromatic hydrocarbons. Cancer Res. 38:2968–2977.Google Scholar
  27. Tinker, J. 1981. Relating mutagenicity to chemical structure. J. Chem. Inf. Comput. Sci. 21:3–7.CrossRefGoogle Scholar
  28. Wishnok, J. S., M. G. Archer, E. S. Edelman, and W. M. Rand. 1978. Nitrosamine carcinogenicity: A quantitative Hansch-Taft structure-activity relationship. Chem. Biol. Interact. 20:43–54.CrossRefGoogle Scholar
  29. Yuan, M., and P. C. Jurs. 1980. Computer-assisted structure-activity studies of chemical carcinogens. Polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 52:294–312.CrossRefGoogle Scholar
  30. Yuta, K., and P. C. Jurs. 1981. Computer-assisted studies of chemical carcinogens. Aromatic amines. J.Med. Chem. 24:241–251.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Kurt Enslein
    • 1
  1. 1.Health Designs Inc.RochesterUSA

Personalised recommendations